Isabella Neri

ORCID: 0000-0003-4019-7373
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pregnancy and preeclampsia studies
  • Gestational Diabetes Research and Management
  • Cardiovascular Issues in Pregnancy
  • Birth, Development, and Health
  • Maternal and fetal healthcare
  • Maternal and Perinatal Health Interventions
  • Bariatric Surgery and Outcomes
  • Nitric Oxide and Endothelin Effects
  • Preterm Birth and Chorioamnionitis
  • Breastfeeding Practices and Influences
  • Complementary and Alternative Medicine Studies
  • Neonatal Respiratory Health Research
  • Menstrual Health and Disorders
  • Acupuncture Treatment Research Studies
  • Pregnancy and Medication Impact
  • Menopause: Health Impacts and Treatments
  • Pregnancy-related medical research
  • Neonatal and fetal brain pathology
  • Assisted Reproductive Technology and Twin Pregnancy
  • Obesity, Physical Activity, Diet
  • Neonatal and Maternal Infections
  • Reproductive System and Pregnancy
  • Folate and B Vitamins Research
  • Blood Coagulation and Thrombosis Mechanisms
  • Grief, Bereavement, and Mental Health

Azienda Unita' Sanitaria Locale Di Modena
2025

University of Modena and Reggio Emilia
2015-2024

Azienda Ospedaliero-Universitaria di Modena
2014-2023

University of Naples Federico II
2023

Umicore (Belgium)
2020

Tescan (Czechia)
2015

University of Messina
2015

United States Congress
2015

University of Rome Tor Vergata
2002-2008

University of Turin
2000

To evaluate whether myo-inositol supplementation, an insulin sensitizer, reduces the rate of gestational diabetes mellitus (GDM) and lowers resistance in obese pregnant women.In open-label, randomized trial, (2 g plus 200 micrograms folic acid twice a day) or placebo (200 was administered from first trimester to delivery women (prepregnancy body mass index 30 greater. We calculated that 101 each arm would be required demonstrate 65% GDM reduction group with statistical power 80% (α=0.05)....

10.1097/aog.0000000000000958 article EN Obstetrics and Gynecology 2015-07-08

Objective: To evaluate whether myo-inositol supplementation may reduce gestational diabetes mellitus (GDM) rate in overweight women.Methods: In an open-label, randomized trial, (2 g plus 200 μg folic acid twice a day) or placebo (200 was administered from the first trimester to delivery pregnant non-obese women (pre-pregnancy body mass index ≥ 25 and < 30 kg/m2). The primary outcome incidence of GDM.Results: From January 2012 December 2014, 220 were at two Italian University hospitals, 110...

10.3109/14767058.2015.1121478 article EN The Journal of Maternal-Fetal & Neonatal Medicine 2015-12-23

Abstract This study aims to determine whether the prescription of a detailed lifestyle programme in overweight/obese pregnant women influences occurrence gestational diabetes (GDM), and if this kind increases adherence healthier comparison standard care. The was designed as randomized controlled trial, with open allocation, enrolling at 9–12 weeks pregnancy BMI ≥ 25 kg/m 2 . assigned Intervention group (I = 96) received hypocaloric, low‐glycaemic, low‐saturated fat diet physical activity...

10.1111/mcn.12333 article EN Maternal and Child Nutrition 2016-09-19

To determine whether changes in lifestyle women with BMI > 25 could decrease gestational weight gain and unfavorable pregnancy outcomes.Women were randomized at 1st trimester to no intervention or a Therapeutic Lifestyle Changes (TLC) Program including diet (overweight: 1700 kcal/day, obese: 1800 kcal/day) mild physical activity (30 min/day, 3 times/week). At baseline the 36th week filled-in Food Frequency Questionnaire.gestational gain, diabetes mellitus, hypertension, preterm delivery....

10.3109/14767058.2013.858318 article EN The Journal of Maternal-Fetal & Neonatal Medicine 2013-11-01

The published data to support recommendations for prevention and management of well-appearing at-risk newborns (WAARNs) early-onset sepsis (EOS) are limited.Retrospective cohort study comparing two different strategies managing WAARNs (≥ 35 weeks' gestation) during a 6-year period (Period 1, from 2005 2007; Period 2, 2009 2011). were defined as healthy-appearing neonates evaluated because risk factors EOS. Laboratory evaluation plus simplified physical examination 1) was compared with alone...

10.3109/14767058.2014.946499 article EN The Journal of Maternal-Fetal & Neonatal Medicine 2014-07-18

Abstract SARS-CoV-2 infection can affect all human beings, including pregnant women. Thus, understanding the immunological changes induced by virus during pregnancy is nowadays of pivotal importance. Here, using peripheral blood from 14 women with asymptomatic or mild infection, we investigate cell proliferation and cytokine production, measure plasma levels 62 cytokines, perform a 38-parameter mass cytometry analysis. Our results show an increase in low density neutrophils but no...

10.1038/s41467-021-24940-w article EN cc-by Nature Communications 2021-07-29

Objective: In many Western countries breech presentation is an indication for elective Cesarean section. order to correct fetal presentation, the stimulation of acupoint BL67 by moxibustion, acupuncture or both has been proposed. Since no studies had previously carried out on populations, pregnant Italian women at 33–35 weeks gestational age carrying a fetus in were enrolled randomized, controlled trial involving active point and observation group.Methods: A total 240 gestation randomized...

10.1080/14767050410001668644 article EN The Journal of Maternal-Fetal & Neonatal Medicine 2004-04-01

Objective: To evaluate the effects of L-arginine (L-Arg) supplementation on clinical outcomes and blood pressure (BP) changes in patients with gestational hypertension. Methods: Patients hypertension proteinuria (n = 28, >300mg/24 h) those without 46) were randomized a double-blind design to receive either L-Arg (20g/500 mL intravenously daily, for 5 days followed by 4g/day orally 2 weeks) or placebo (PL). The primary outcome variable was time from randomization delivery (Latency). Automated...

10.1080/10641950601147994 article EN Hypertension in Pregnancy 2007-01-01

Objective. To evaluate l-arginine (l-Arg) supplementation in pregnant women with chronic hypertension and its effects on blood pressure (BP) maternal neonatal complications.Methods. We enrolled 80 affected by mild referred to the High Risk Clinic of Mother–Infant Department University Modena Reggio Emilia. Each woman after obtaining oral consent was randomized receive l-Arg versus placebo thereafter submitted 24-h ambulatory BP monitoring. The primary outcome change 10–12 weeks treatment....

10.3109/14767051003677962 article EN The Journal of Maternal-Fetal & Neonatal Medicine 2010-10-20

Objective To evaluate outcome in the pregnancy following a stillbirth (SB) by placental vascular disorders. Study Design A prospective, observational, multicenter study was conducted woman with history of (> 22 weeks) between 2005 and June 2013, 3 Italian University Hospitals. Causes SB were previously identified after extensive investigations. Pregnant women enrolled within first trimester. The main "adverse neonatal outcome", including perinatal death, fetal growth restriction, early...

10.1371/journal.pone.0155761 article EN cc-by PLoS ONE 2016-05-26

Childbirth education classes are antenatal support services offered to pregnant women or the couple, aimed at increasing their knowledge regarding pregnancy, labour, delivery, breastfeeding, parenthood and newborn care.The aim was evaluate effectiveness of Birthing Classes through analysis occurrence C-section, epidural analgesia, behavior during labor delivery who participated course as compared those did not attend it. Moreover, level satisfaction attended measured with a questionnaire 20...

10.7417/ct.2020.2193 article EN PubMed 2019-12-19

Background To evaluate the effects of L‐arginine (ARG) infusion, nitric oxide as substrate. on utero‐placental circulation at third trimester. Methods Three groups nine pregnant women each were infused i.v. with 30 g ARG, for minutes. One group served control, and two remnants composed by patients intrauterine growth retardation (IUGR‐B) or without (IUGR‐A) increased resistances in circulation. Changes blood flow velocity waveforms both uterine arteries umbilical artery recorded 60 Blood...

10.3109/00016349609047088 article EN Acta Obstetricia Et Gynecologica Scandinavica 1996-03-01

•Women of child-bearing age who are HCV positive undergo premature ovarian senescence.•Such women have fewer live births, and higher rates miscarriage gestational diabetes.•Total fertility rate in vs. the general population is 0.7 1.37.•Miscarriage significantly reduced by successful treatment.•Antivirals should be tested for their effects on other adverse pregnancy outcomes. Background & AimsPremenopausal (HCV+) failing function, which likely to impact fertility. Thus, we investigated...

10.1016/j.jhep.2017.08.019 article EN cc-by-nc-nd Journal of Hepatology 2017-09-05

To investigate the comorbidity of premenstrual syndrome (PMS) and menstrual migraine, Menstrual Distress Questionnaire (MDQ) was prospectively administered for two consecutive cycles to 22 patients with 12 cases migraine without aura 15 PMS. MDQ scores varied throughout cycle in each patient group, wider changes being shown by Fourteen 4 achieved diagnostic criteria PMS over cycles. In these did not differ from sufferers at any stage cycle. The increase cluster symptoms identical subjects...

10.1046/j.1468-2982.1993.1306422.x article EN Cephalalgia 1993-12-01
Coming Soon ...